Mesterolone, an androgenic medication used primarily to treat low testosterone levels, was developed in the mid-20th century and introduced for medical use in the 1960s. Its history is marked by its role in managing male hypogonadism and infertility, as well as its unique profile of having relatively low anabolic but significant androgenic activity. Mesterolone, an orally active androgen, has been used in various hormone therapies and is known for not significantly suppressing natural testosterone production compared to other anabolic steroids. Its development included clinical studies evaluating its safety and efficacy, leading to its adoption in several treatment protocols, particularly in Europe.
BRAND NAMES
Proviron
Mesterolone Bayer
Androviron
MECHANISM OF ACTION
The mechanism of action of Mesterolone involves its function as a synthetic androgen that binds to intracellular androgen receptors in target tissues. After binding, the drug–receptor complex translocates to the nucleus, where it regulates gene transcription and promotes the synthesis of proteins responsible for androgenic effects such as maintenance of male secondary sexual characteristics, libido, and spermatogenesis.
PHARMACOKINETICS
Absorption
Mesterolone is well absorbed after oral administration due to its chemical structure, which allows it to resist rapid hepatic metabolism. Unlike many other oral androgens, it is not significantly inactivated during first-pass metabolism in the liver, leading to adequate systemic availability.
Distribution
Mesterolone has a relatively moderate volume of distribution, indicating that it distributes beyond the bloodstream into body tissues, particularly those sensitive to androgens such as the prostate, skin, and reproductive organs.
Metabolism
Mesterolone is metabolized primarily in the liver, where it undergoes reduction and conjugation to form inactive metabolites. Unlike many other oral androgens, it is not 17-alpha alkylated, which reduces the risk of hepatotoxicity.
Elimination
Mesterolone is eliminated primarily through the kidneys in the form of its inactive metabolites. After hepatic metabolism, these metabolites are excreted in the urine, with a smaller proportion eliminated via feces.
PHARMACODYNAMICS
Mesterolone exerts its pharmacodynamic effects by acting as a potent androgen receptor agonist, mimicking the actions of endogenous testosterone in target tissues. It enhances androgen-dependent physiological processes such as the development and maintenance of male secondary sexual characteristics, stimulation of libido, and support of spermatogenesis.
ADMINISTRATION
Mesterolone is administered orally in tablet form. It is typically taken in divided doses throughout the day to maintain stable blood levels due to its relatively short half-life. The dosage and duration of treatment depend on the indication, such as male hypogonadism or infertility, and should be individualized based on patient response and clinical condition.
DOSAGE AND STRENGTH
Mesterolone is most commonly available as oral tablets in a standard strength of 25 mg. The dosage varies depending on the clinical indication, with typical regimens ranging from 25 mg two to three times daily for conditions such as male hypogonadism and infertility. In some cases, dosing may be adjusted to once or twice daily as maintenance therapy based on patient response and hormone levels.
DRUG INTERACTIONS
Mesterolone may interact with other hormonal agents and medications that influence hepatic enzyme activity or androgen/estrogen balance. Concomitant use with other androgens or anabolic steroids can enhance androgenic effects and increase the risk of adverse reactions such as acne, fluid retention, and mood changes.
FOOD INTERACTIONS
Mesterolone has no clinically significant or well-established food interactions. It can generally be taken with or without food, although taking it after meals may help reduce the possibility of mild gastrointestinal discomfort in some individuals. Food does not meaningfully affect its absorption or overall bioavailability.
CONTRAINDICATIONS
Mesterolone is contraindicated in conditions where androgen exposure may worsen disease or pose safety risks. It should not be used in patients with known or suspected prostate carcinoma or androgen-dependent tumors, as androgens can stimulate tumor growth.
SIDE EFFECTS
Acne and oily skin
Increased body or facial hair growth (hirsutism-like effects in susceptible individuals)
Mood changes (irritability, aggression, or mood swings)
Headache
Gynecomastia (rare, but possible via hormonal imbalance in sensitive individuals)
Suppression of endogenous testosterone.
OVER DOSE
Overdose with Mesterolone is uncommon and serious toxicity data are limited, but excessive intake may intensify its androgenic effects. Possible symptoms include severe acne, marked mood changes (irritability, aggression), headache, gastrointestinal discomfort, and fluid retention.
TOXICITY
Toxicity from Mesterolone is generally considered low compared to many other oral anabolic-androgenic steroids, largely because it is not a 17-alpha alkylated compound and has a reduced risk of severe hepatotoxicity.
